The Question of HIV Vaccine: Why Is a Solution Not Yet Available?
Ever since its discovery, human immunodeficiency virus type 1 (HIV-1) infection has remained a significant public health concern. The number of HIV-1 seropositive individuals currently stands at 40.1 million, yet definitive treatment for the virus is still unavailable on the market. Vaccination has...
Saved in:
| Main Authors: | Martina Libera, Valeria Caputo, Giulia Laterza, Louiza Moudoud, Alessio Soggiu, Luigi Bonizzi, Roberta A. Diotti |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-01-01
|
| Series: | Journal of Immunology Research |
| Online Access: | http://dx.doi.org/10.1155/2024/2147912 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
AMR Surveillance in Africa: Are We There Yet?
by: Prof Sabiha Essack, et al.
Published: (2025-03-01)
by: Prof Sabiha Essack, et al.
Published: (2025-03-01)
Similar Items
-
Why are CGRP monoclonal antibodies not yet the first line treatment in migraine prevention?
by: Caio Vinicius de Meira Grava Simioni
Published: (2022-08-01) -
Lactic Acid Bacteria (LAB) and Their Bacteriocins for Applications in Food Safety Against <i>Listeria monocytogenes</i>
by: Cristian Piras, et al.
Published: (2025-06-01) -
Terraforming Mars is not out of the question yet - and microscopic algae could help
by: Iv. Vasileva, et al.
Published: (2019-03-01) -
Why Does Intelligence Fail Yet We All Have to Learn from Mistakes?
by: A. R. Margoev
Published: (2022-06-01) -
Why Commodity Booms Have Not (Yet?) Boosted Human Capital: Bolivia’s Struggle to Create a Skilled Workforce
by: Fritz Brugger, et al.
Published: (2014-11-01)